AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Director's Dealing 2025

Dec 4, 2025

34519_dirs_2025-12-04_afeb255e-b08f-494d-9469-a27c24f7fe96.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2025-12-03

Reporting Person: te Boekhorst Paul Francis Olivier (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-12-03	Common Stock $0.10 par value per share	P	3598	$5.045	Acquired	7306	Direct
2025-12-04	Common Stock $0.10 par value per share	P	2432	$5.50020	Acquired	9738	Direct

Footnotes

F1: This amendment amends the previously reported transaction effective on 12/3 to disclose the correct amount and price of shares purchased.

F2: This amendment amends the previously reported transaction effective on 12/3 to disclose the correct amount and price of shares purchased, and the correct transaction date.